Celularity annual return on equity
2022
2023
2024
Celularity Return on Equity (ROE) Growth & History (CELU)
Celularity's return on equity was −232.51% for fiscal 2024.
View full Celularity company overviewCelularity annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −232.51% | −68.84 pp |
| 2023 | 2023-12-31 | −163.67% | −173.19 pp |
| 2022 | 2022-12-31 | 9.51% | — |
Celularity quarterly return on equity
Q2.19
Q3.19
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −1,186.07% | −1125.10 pp |
| Q4 2024 | 2024-12-31 | −101.80% | −128.61 pp |
| Q3 2024 | 2024-09-30 | −71.40% | +54.82 pp |
| Q2 2024 | 2024-06-30 | −21.97% | +13.01 pp |
| Q1 2024 | 2024-03-31 | −60.97% | −24.86 pp |
| Q4 2023 | 2023-12-31 | 26.81% | +13.36 pp |
| Q3 2023 | 2023-09-30 | −126.22% | −129.27 pp |
| Q2 2023 | 2023-06-30 | −34.98% | −74.83 pp |
| Q1 2023 | 2023-03-31 | −36.11% | +30.30 pp |
| Q4 2022 | 2022-12-31 | 13.46% | +17.59 pp |
| Q3 2022 | 2022-09-30 | 3.05% | — |
| Q2 2022 | 2022-06-30 | 39.85% | — |
| Q1 2022 | 2022-03-31 | −66.41% | — |
| Q4 2021 | 2021-12-31 | −4.13% | — |
| Q3 2019 | 2019-09-30 | 22.42% | — |
| Q2 2019 | 2019-06-30 | 25.27% | — |
Celularity return on equity trends
Between the periods ended 2022-12-31 and 2024-12-31, Celularity's return on equity decreased from 9.51% to −232.51%, a change of −242.03 percentage points. The latest reported quarter, Q1 2025, shows −1,186.07%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celularity source filings ↗